BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16758914)

  • 1. [The ethiology, pathogenesis, and treatment of Helicobacter pylori-associated peptic ulcer: the status of the problem and the prospects].
    Tsimmerman IaS
    Klin Med (Mosk); 2006; 84(3):9-19. PubMed ID: 16758914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].
    Vestergård A; Bredahl K; de Muckadell OB; Pedersen OB; Hansen JM
    Ugeskr Laeger; 2009 Jan; 171(4):235-9. PubMed ID: 19174039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence of peptic ulcer in uraemic and non-uraemic patients after Helicobacter pylori eradication: a 2-year study.
    Tseng GY; Lin HJ; Fang CT; Yang HB; Tseng GC; Wang PC; Hung TL; Deng YC; Cheng YT; Huang CH
    Aliment Pharmacol Ther; 2007 Sep; 26(6):925-33. PubMed ID: 17767477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease.
    Wu CY; Kuo KN; Wu MS; Chen YJ; Wang CB; Lin JT
    Gastroenterology; 2009 Nov; 137(5):1641-8.e1-2. PubMed ID: 19664631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral health status and oral hygiene practices of patients with peptic ulcer and how these affect Helicobacter pylori eradication from the stomach.
    Namiot DB; Namiot Z; Kemona A; Bucki R; Gotebiewska M
    Helicobacter; 2007 Feb; 12(1):63-7. PubMed ID: 17241303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease.
    Jang EJ; Park SW; Park JS; Park SJ; Hahm KB; Paik SY; Sin MK; Lee ES; Oh SW; Park CY; Baik HW
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S278-85. PubMed ID: 19120912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Indications to surgical treatment of patients with peptic ulcer disease].
    Girdaladze A M ; Mosidze BA; Elisabedashvili GV; Bolkvadze TD; Dzhorbenadze TA
    Georgian Med News; 2008 Apr; (157):11-7. PubMed ID: 18487682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The evaluation of the gastroprotective effect of sucralfate in Helicobacter pylori-associated gastric ulcer].
    Pavlenko OA; Samoĭlova AV; Krivova NA; Zaeva OB
    Klin Med (Mosk); 2007; 85(10):65-7. PubMed ID: 18154186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori-negative nonsteroidal anti-inflammatory drug-negative ulcer.
    McColl KE
    Gastroenterol Clin North Am; 2009 Jun; 38(2):353-61. PubMed ID: 19446263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk factors for peptic ulcer recurrence].
    Rodríguez-Hernández H; Jacobo-Karam JS; Guerrero-Romero F
    Gac Med Mex; 2001; 137(4):303-10. PubMed ID: 11519353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Methods for increasing the efficacy and safety of Helicobacter pylori eradication regimens].
    Zakharova NV
    Eksp Klin Gastroenterol; 2006; (4):59-66. PubMed ID: 17269426
    [No Abstract]   [Full Text] [Related]  

  • 13. [Helicobacter pylori infection: extragastric effects and diseases (a critical analysis)].
    Tsimmerman IaS
    Klin Med (Mosk); 2006; 84(4):63-7. PubMed ID: 16755861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Etiology and pathogenesis of peptic ulcer].
    Bytov MA
    Eksp Klin Gastroenterol; 2003; (5):5-9, 192. PubMed ID: 14621602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interleukin-1beta gene polymorphism as a predictor of eradication treatment efficacy in gastric and duodenal ulcer associated with Helicobacter pylori].
    Oganesian TS
    Eksp Klin Gastroenterol; 2008; (4):92-6. PubMed ID: 19145908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathogen eradication prevents gastrointestinal complications].
    MMW Fortschr Med; 2007 Oct; 149(43):58-9. PubMed ID: 17992910
    [No Abstract]   [Full Text] [Related]  

  • 18. [Gastroduodenal diseases and Helicobacter pylori infection: overview].
    Tsimmerman IaS
    Klin Med (Mosk); 2009; 87(5):9-15. PubMed ID: 19565820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of Helicobacter pylori infection in patients with peptic ulcer perforation.
    Andreson H; Sillakivi T; Peetsalu M; Peetsalu A; Mikelsaar M
    Scand J Gastroenterol; 2007 Mar; 42(3):324-9. PubMed ID: 17354111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori infection in peptic ulcer disease: the importance of smoking and ethnicity.
    Pillay KV; Htun M; Naing NN; Norsa'adah B
    Southeast Asian J Trop Med Public Health; 2007 Nov; 38(6):1102-10. PubMed ID: 18613553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.